Moesin and CD44 expression in cutaneous melanocytic tumours

British Journal of Dermatology

Volumn 138, Issue 5, 1998, Pages 763-768

  Ichikawa, T ^a   Masumoto, J ^a   Kaneko, M ^a   Saida, T ^a   Sagara, J ^a   Taniguchi, S ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EZRIN; HERMES ANTIGEN; MOESIN; PARAFFIN; RADIXIN;

ACTIN FILAMENT; ARTICLE; BLUE NEVUS; CELL MEMBRANE; CONTROLLED STUDY; DYSPLASTIC NEVUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JUVENILE MELANOMA; LYMPH NODE METASTASIS; MELANOCYTIC NEVUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; SKIN METASTASIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD44; ANTIGENS, NEOPLASM; BLOTTING, WESTERN; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; MELANOMA; MICROFILAMENT PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; NEVUS, EPITHELIOID AND SPINDLE CELL; NEVUS, PIGMENTED; PROTEINS; SKIN NEOPLASMS;

EID: 0031780745     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1998.02255.x     Document Type: Article

References (26)

1. Lankes WT, Griesmacher A, Grünwald J et al. A heparin-binding protein involved in inhibition of smooth-muscle cell proliferation. Biochem J 1988; 251: 831-42.
2. Lankes WT, Furthmayr H. Moesin: a member of the protein 4.1-talin-ezrin family of proteins. Proc Natl Acad Sci USA 1991; 88: 8297-301.
3. Takeuchi K, Sato N, Kasahara H et al. Perturbation of cell adhesion and microvilli formation by antisense oligonucleotides to ERM family members. J Cell Biol 1994; 125: 1371-84.
4. Tsukita S, Oishi K, Sato N et al. ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J Cell Biol 1994; 126: 391-401.
5. Tsukita S, Yonemura S, Tsukita S et al. ERM proteins: head-to-tail regulation of actin-plasma membrane interaction. Trends Biochem Sci 1997; 22: 53-8.
6. Lesley J, Hyman R, Kincade PW. CD44 and its interaction with extracellular matrix. Adv Immunol 1993; 54: 271-335.
7. Wang C, Tammi M, Tammi R. Distribution of hyaluronan and its CD44 receptor in the epithelia of human skin appendages. Histochemistry 1992; 98: 105-12.
8. Screaton GR, Bell MV, Jackson DG et al. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992; 89: 12160-4.
9. Günthert U, Hofmann M, Rudy W et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991; 65: 13-24.
10. Heider KH, Hofmann M, Hors E et al. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol 1993; 120: 227-33.
11. Heider KH, Dämmrich J, Skroch-Angel P et al. Differential expression of CD44 splice variants in intestinal-and diffuse-type human gastric carcinomas and normal gastric rnucosa. Cancer Res 1993; 53: 4197-203.
12. Friedrichs K, Franke F, Lisboa BW et al. CD44 isoforms correlate with cellular differentiation but not with progression in human breast cancer. Cancer Res 1995; 55: 5424-33.
13. Bourguignon LYW, Iida N, Welsh CF et al. Involvement of CD44 and its variant isoforms in membrane-cytoskeleton interaction. cell adhesion and tumor metastasis. J Neurol Oncol 1995; 26: 201-8.
14. Harwood CA, Green MA, Cook MG, et al. CD44 expression in melanocytic lesions: a marker of malignant progression? Br J Dermatol 1996; 135: 876-82.
15. Ackerman AB, Mihara I. Dysplasia, dysplastic melanocytes. dysplastic nevi, the dysplastic nevus syndrome, and the relation between dysplastic nevi and malignant melanomas. Hum Pathol 1985; 16: 87-91.
16. Trofatter JA, MacCollin MM, Rutter JL et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 1993; 72: 791-800.
17. Berryman M, Franck Z, Bretscher A. Ezrin is concentrated in the apical microvilli of a variety of epithelial cells whereas moesin is found primarily in endothelial cells. J Cell Sci 1993; 105: 1025-43.
18. Dunster LM, Schneider-Schaulies J, Löffler S et al. Moesin: a cell membrane protein linked with susceptibility to measles virus infection. Virology 1994; 198: 265-74.
19. Nakamura H, Ozawa H. Immunolocalization of CD44 and the ERM family in bone cells of mouse tibiae. J Bone Miner Res 1996; 11: 1715-22.
20. Seelentag WKF, Günthert U, Saremaslani P et al. CD44 standard and variant isoform expression in human epidermal skin tumors is not correlated with tumor aggressiveness but down-regulated during proliferation and tumor de-differentiation. Int J Cancer 1996; 69: 218-24.
21. Dommann SNW, Ziegler T, Dommann-Schener CC et al. CD44v6 is a marker for systemic spread in cutaneous T-cell lymphomas. J Cutan Pathol 1995; 22: 407-12.
22. Seiter S, Schadendorf D, Herrmann K et al. Expression of CD44 variant isoforms in malignant melanoma. Clin Cancer Res 1996; 2: 447-56.
23. Manten-Horst E, Danen EHJ, Smit L et al. Expression of CD44 splice variants in human cutaneous melanoma and melanoma cell lines is related to tumor progression and metastatic potential. Int J Cancer 1995; 64: 182-8.
24. Fernández-Figueras MT, Ariza A, Calatrava A et al. CD44 and melanocytic tumors: a possible role for standard CD44 in the epidermotropic spread of melanoma. J Cutan Pathol 1996; 23: 133-9.
25. Seelentag WFK, Böni R, Güthert U et al. Expression of CD44 isoforms and β1,6-blanched oligosaccharides in human malignant melanoma is correlated with tumor progression but not with metastatic potential. J Cutan Pathol 1997; 24: 206-11.
26. Leigh C, Palechek P, Knutson J et al. CD44 expression in benign and malignant nevomelanocytic lesions. Hum Pathol 1996; 27: 1288-94.